Cascades Q1 2026 slides: profitability pressures mount amid cost headwinds

Cascades reported Q1 2026 adjusted EPS of CAD $0.07, well below the CAD $0.1367 consensus, on revenue of CAD $1.13B versus CAD $1.15B expected. Adjusted EBITDA fell 22% sequentially to $118M as higher logistics, chemical, energy, and operating costs outweighed price and asset-sale benefits, while Q2 adjusted EBITDA guidance of $104M-$118M signals continued pressure. The stock fell 1.83% after the release, and management flagged ongoing macro, demand, and cost headwinds despite asset monetization progress.

Analysis

CAS is a classic “cost inflation + weak volume + low pricing power” setup, but the second-order issue is more important: management is trying to de-risk the balance sheet through asset monetization while the core businesses are still throwing off muted cash. That usually helps equity holders only after the market becomes convinced the earnings floor is real; until then, every asset sale can look like bridge financing for structurally lower EBITDA.

The key loser set is not just CAS. Corrugated/containerboard peers with similar recycled-fiber exposure and North American logistics intensity should see the same margin pressure, but CAS is more exposed because its mix is more sensitive to cyclical industrial demand and its turnaround narrative is already crowded with execution risk. If pricing discipline fails to hold, customers can delay replenishment for 1-2 quarters and force a volume reset that overwhelms any input-cost relief.

The contrarian angle is that the market may be underestimating operating leverage on the upside if recycled fiber and energy stay contained while announced price increases stick into Q2/Q3. That said, the bar is low only if management can prove stable throughput at the problem assets and convert one-off gains into recurring EBITDA. The stock likely needs a clean sequential inflection in Q2 and evidence that leverage is trending toward low-3x or better before multiple expansion is credible.

For catalysts, watch for three things over the next 30-90 days: announced price pass-throughs actually showing up in order books, any further estimate cuts from analysts, and whether asset-sale proceeds are deployed to reduce debt rather than support working capital. A miss on Q2 guide midpoint would likely force another de-rating, while a beat would mostly validate the bear case is less severe rather than create immediate upside.

Key Decisions for Investors

• Short CAS.TO on any strength into the next 2-4 weeks; thesis is that the market is still underpricing margin compression and estimate revisions. Risk/reward: favorable if Q2 pricing fails to offset logistics/energy, with downside to prior support if guidance slips.
• Pair trade: long a more diversified packaging name vs short CAS.TO over 1-3 months. The cleaner balance sheet and better mix should outperform if the sector rerates on stable fiber costs.
• Buy short-dated downside protection on CAS.TO ahead of the next earnings/guidance print. Best use case is a 1-2 month put spread to monetize a continued “show-me” period without overpaying for volatility.
• If you want to own the thesis, wait for a confirmed Q2 EBITDA inflection and a debt paydown update; otherwise the equity is trading like a turnaround without enough margin of safety.